Sign inJoin waitlistJoin the waitlist

Vijay Bhoj

Pathology / Anatomic Pathology & Clinical Pathology · University of Penn - Medical Group

Credentials: · · ·

History

University of Pennsylvania
2013–2018
Blood Banking/Transfusion Medicine
Hospital of the University of Pennsylvania
2013–2014
Hospital of the University of Pennsylvania
2013–2014
Pathology-Anatomic and Clinical
University of Pennsylvania Health System
2006–2010
University of Texas Southwestern Medical Center
2007–2010
Univ of Texas Southwestern Med Sch at Dallas
2006–2010

Research

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
New England Journal of Medicine · 2017 · 1,525 citations
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Science · 2016 · 614 citations
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Case report · Nature Medicine · 2018 · 542 citations

Michael Milone
11 papers
Ali Naji
10 papers
Carl June
8 papers
Divyansh Agarwal
6 papers · 5 as a resident
Marco Ruella
6 papers · 1 as a fellow
Stephen Schuster
6 papers
David Porter
5 papers
Alfred Garfall
4 papers
Shannon Maude
4 papers
Zhibin Chen
4 papers
Ana Gomez
3 papers
Asunción Mejías
3 papers · 2 as a fellow

Grants

Innovative Strategies to Inhibit Humoral Immunity in Renal Xenotransplantation
National Institute of Allergy and Infectious Diseases · R01
PI · $1.3M · University of Pennsylvania
2026–2031
Immune Repertoire Remodeling Following B Cell-Targeted CAR T Cells for Induction of Renal Allograft Tolerance in Non-Human Primates
National Institute of Allergy and Infectious Diseases · R01
PI · $3.3M · University of Pennsylvania
2025–2030
Selective B Cell Depletion Using Engineered T Cells As A Curative Treatment For Acquired Thrombotic Thrombocytopenic Purpura
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · University of Pennsylvania
2025–2029
Autologous Chimeric Antigen Receptor Engineered T Cell Immunotherapy for Desensitization in Patients Awaiting Kidney Transplantation
National Institute of Allergy and Infectious Diseases · U01
PI · $19.2M · University of Pennsylvania
2021–2028

Clinical trials

CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Study chair · Recruiting · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2024–2042